Herbalife grants CFO 3,391 stock-linked rights

The award vests in three one-third installments from 2027 through 2029, with continued service required through each vesting date.

Available on EDGAR 11/06/2026 - 04:45 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:45 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Herbalife Ltd. (HLF) granted its Chief Financial Officer, Scott Stephen Schaefer, 3,391 stock appreciation rights on November 4, 2026, tied to Common Stock. The rights were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan, have a $15.31 exercise price, and expire November 4, 2036. They vest in one-third increments on November 4, 2027, November 4, 2028, and November 4, 2029, subject to continued service through each vesting date.

Insider Trade Summary

Grant/Award: 3,391 shares

Grant/Award 1 txn

Insider Schaefer Scott Stephen

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Appreciation Rights F1	3,391	$0.00	$0.00

Holdings After Transaction: Stock Appreciation Rights — 3,391 contracts (Direct)

Holdings Before and After: Stock Appreciation Rights, 0 to 3,391 contracts (Direct)

Footnotes (1)

1. F1. Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of November 4th, 2027, November 4th, 2028, and November 4th, 2029, subject to continued service through such date.

Key Figures

Stock appreciation rights granted: 3,391 rights Exercise price: $15.31 per share Vesting installments: One-third increments +1 more

4 metrics

Stock appreciation rights granted 3,391 rights Granted November 4, 2026

Exercise price $15.31 per share For the stock appreciation rights

Vesting installments One-third increments November 4, 2027, November 4, 2028, and November 4, 2029; subject to continued service through each date

Expiration date November 4, 2036 Stock appreciation rights

Key Terms

stock appreciation rights, exercise price, Amended and Restated 2023 Stock Incentive Plan

3 terms

stock appreciation rights financial

"Consists of stock appreciation rights ("SARs") granted"

Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.

exercise price financial

"exercise price of $15.31"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Amended and Restated 2023 Stock Incentive Plan financial

"granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When do the HLF CFO's stock appreciation rights vest?

The rights vest in one-third increments on November 4, 2027, November 4, 2028, and November 4, 2029, subject to continued service through each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schaefer Scott Stephen

(Last) (First) (Middle)

800 WEST OLYMPIC BOULEVARD

SUITE 406

(Street)

LOS ANGELES CALIFORNIA 90015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HERBALIFE LTD. [ HLF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$15.31(1)	11/04/2026		A		3,391		(1)	11/04/2036	Common Stock	3,391	$0	3,391	D

Explanation of Responses:

1. Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of November 4th, 2027, November 4th, 2028, and November 4th, 2029, subject to continued service through such date.

	/s/ Alaaeddine Sahibi, as Attorney-In-Fact for Scott Schaefer	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)